Evotaz

Active Ingredient(s): Atazanavir + Cobicistat
FDA Approved: * January 29, 2015
Pharm Company: * BRISTOL MYERS SQUIBB
Category: HIV / AIDS

Atazanavir, sold under the brand name Reyataz among others, is an antiretroviral medication used to treat HIV/AIDS.[2] It is generally recommended for use with other antiretrovirals.[2] It may be used for prevention after a needlestick injury or other potential exposure (postexposure prophylaxis (PEP)).[2] It is taken by mouth once a day.[2] Common side effects include headache, nausea, yellowish skin, abdominal pain, trouble sle... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Evotaz Oral Tablet
NDC: 0003-3641
Labeler:
E.r. Squibb & Sons, L.L.C.
Evotaz Oral Tablet
NDC: 50090-1724
Labeler:
A-s Medication Solutions
Evotaz Oral Tablet
NDC: 54569-6595
Labeler:
A-s Medication Solutions